The 2nd International Ferticlinic Fertility & IVF Conference concluded in Abu Dhabi on 25 January, bringing global experts together to discuss advances in IVF, reproductive medicine, and the emerging role of artificial intelligence in fertility care.

The 2nd International Ferticlinic Fertility & IVF Conference (2nd IFFIC) concluded in Abu Dhabi after three days of high-level scientific discussions held from 23 to 25 January, reinforcing the emirate’s position as a leading international hub for reproductive medicine and advanced fertility care. The conference attracted more than 2,000 visitors and featured over 65 international speakers, bringing together prominent physicians, researchers, policymakers, and healthcare leaders to examine the future of fertility treatments, medical innovation, and patient-centred care.

Also Read: University of Waterloo Researchers Use Machine Learning to Accelerate Drug Development and Personalised Medicine

Held under the theme “Abu Dhabi Leads the World in IVF Excellence,” the conference reflected the emirate’s rapid progress in assisted reproductive technologies, supported by strong clinical outcomes, robust regulatory frameworks, and a forward-looking vision grounded in scientific research, innovation, and ethical practice. These factors collectively position Abu Dhabi at the forefront of global fertility innovation.

The conference programme offered a comprehensive and forward-thinking agenda that combined scientific excellence with practical insight. Over the three days, participants engaged in interactive sessions with leading experts in reproductive medicine, explored the latest clinical advances, and took part in hands-on learning experiences aligned with the rapidly evolving landscape of fertility care and medical innovation.

The agenda featured high-level keynote addresses by national and international health leaders who have contributed to shaping the future of healthcare. In-depth scientific sessions addressed advances in IVF, fertility preservation, genetics, fetal medicine, and the management of complex reproductive cases. The conference also hosted focused discussions on the role of artificial intelligence in fertility care, examining both its potential applications and the challenges associated with its integration into clinical practice.

Highlighting the significance of the event, Dr. Nagwan Ahmed, Conference President, Professor of Obstetrics, Gynecology and Infertility, and Head of the Academics and Research Department at Ferticlinic Group, said: “The 2nd International Ferticlinic Fertility & IVF Conference reflects Abu Dhabi’s remarkable progress in reproductive medicine. This conference is designed not only to showcase scientific excellence, but also to foster global collaboration, support scientific research, and help shape the future of IVF through innovation, ethical practices, and patient-centered care.”

Click here to join our WhatsApp channel here

Dr. Elsamawal El Hakim, Chief Executive Officer and Medical Director of the Ferticlinic Group, said: “Abu Dhabi has succeeded in building an integrated health ecosystem that combines clinical excellence, strong regulatory governance, innovation, and an enhanced patient experience. Through this scientific gathering, we aim to further solidify Abu Dhabi’s position as a global benchmark in IVF, research, and fertility education, while contributing to the advancement of sustainable healthcare both locally and internationally.”